NIH | National Cancer Institute | NCI Wiki  

Date

Meeting cancelled. No data submission requests to review.

Attendees

Committee MemberPresentAbsent
X
X
Warren Kibbe



Gregory Tawa

William Hendriks

Matthew Breen
X
Roel Verhaak



Goals

  • Review, discuss, and prioritize ICDC study submission proposals

Outstanding Action items

Agenda

Discussion ItemWhoNotes
Study Queue
  • OSA04: 
    • Osteosarcoma study from Auburn University
    • 7 cases
    • Clinical and Transcriptomic data
    • Status: Kick off call to be planned
  • COTC021
    • "Evaluation of Orally Administered mTOR inhibitor Rapamycin in Dogs in the Adjuvant Setting with Osteosarcoma"
    • This is the parallel arm to COTC022: SOC in dogs with Osteosarcoma that was previously uploaded to the ICDC
    • Clinical data for 152 dogs. mRNAseq for 93 dogs
    • Status: Fully loaded on the Dev environment. Testing pending.
  • UBC03
    • "Transcriptomic analyses of early stage bladder cancer in Scottish Terriers detected through screening"
    • Purdue University
    • 19 cases
    • Status: Recently met with submitters for a final review of template-based loading files. Additional edits were requested and new versions are pending from the submitter.
  • OSA02
    • "Immune Pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma"
    • Colorado State University
    • 108 cases
    • Status: Template-based loading files have been received and reviewed and there is a call set up to resolve minor issues
  • PRECINCT01 
    • "Inhaled IL-15 Immunotherapy for Treatment of Lung Metastases"
    • UC Davis
    • 21 cases
    • Status: Pathology reports and adverse event data have been indexed by DCF, the study is pending testing by the ICDC team
  • PRECINCT02
    • "Novel treatments for Diffuse large B cell lymphoma (DLBCL) in dogs"
    • Tufts University
    • 49 cases
    • Status: All clinical data has been submitted. Validation errors are pending fixes. Genomics data to be submitted.
  • PANCAN01
    • "Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds"
    • University of Georgia
    • 684 cases
    • Status: Waiting on response from submitter

Minutes (Not Verbatim)



Action items